Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
Abroad (travel likely)RecruitingPHASE2
Conditions
Acute Monocytic Leukemia · Acute Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
OHSU Knight Cancer Institute, Portland, Oregon, United States
Contact: Principal Investigator (Curtis A. Lachowiez)
Study leads
Curtis A Lachowiez
Principal Investigator
OHSU Knight Cancer Institute